#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Postprandial hypoglycaemia Penile cancer Cystic fibrosis Hodgkin's disease refractory Red blood cell abnormality Haematological malignancy Pituitary-dependent Cushing's syndrome Anal cancer recurrent Transitional cell cancer of the renal pelvis and ureter Primary hyperoxaluria Undifferentiated sarcoma Paget's disease of the vulva Juvenile chronic myelomonocytic leukaemia Chronic cutaneous lupus erythematosus Exudative retinopathy More trials…

    Learn about Rare Diseases

    Marfan’s syndrome – Basic Information Nephroblastoma – Diagnostics Focal segmental glomerulosclerosis – Diagnostics Choroid melanoma – Life with Disease Familial amyotrophic lateral sclerosis – Basic Information Atypical haemolytic uraemic syndrome – Life with Disease Short-bowel syndrome Aicardi-Goutieres syndrome – Treatment Adrenogenital syndrome – Life with Disease Idiopathic pulmonary fibrosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Parsaclisib Hydrochloride Ly3819469 Sodium RNMB1 Carbetocin Povidone, Iodinated Lixisenatide Milademetan ABIRATERONE DECANOATE ARLOCABTAGENE AUTOLEUCEL Valsartan Relugolix ZAMPILIMAB Pemigatinib Cefepime Hydrochloride Eribulin Elritercept Treprostinil Taxanes Estradiol Valerate Diacerein More therapies…

    Learn about Your Condition

    Toxic nodular goitre Osteosarcoma Dementia Alzheimer's type Intracranial aneurysm Hypertension Prader-Willi syndrome Benign neoplasm of ureter Colon cancer Varices oesophageal Henoch-Schonlein purpura Subdural haematoma Schizoaffective disorder Genital herpes simplex Chronic disease Supraventricular tachycardia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colorectal cancer metastatic

  • Study on the Effects of Fluorouracil and Capecitabine in Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    Finland

  • Study of Arfolitixorin, 5-Fluorouracil, Oxaliplatin, and Bevacizumab for Patients with Metastatic Colorectal Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • ARFOLITIXORIN
    • Calcium Folinate
    Germany

  • Study comparing oxaliplatin and irinotecan chemotherapy effectiveness using tumor testing in patients with metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    • Oxaliplatin
    Norway

  • Study on Regorafenib with Cyclophosphamide, Capecitabine, and Aspirin for Patients with Metastatic Colorectal Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • D,L-Lysine Acetylsalicylate
    • Regorafenib
    France

  • Study on Cetuximab, Irinotecan, and Fluorouracil for First-Line Treatment in Patients with Advanced Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Irinotecan
    • Cetuximab
    • Fluorouracil
    Italy

  • Study on Cetuximab-Based Treatment for Metastatic Colorectal Cancer in Patients with RAS/BRAF Wild Type Tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    • Fluorouracil Sodium
    Italy
Previous Page
1 2 3 4 5 6 … 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!